Asymptomatic hemorrhage after thrombolysis may not be benign: Prognosis by hemorrhage type of the Canadian alteplase for stroke effectiveness study registry [10]

Stroke

Volumn 38, Issue 9, 2007, Pages

  Libman, Richard ^a   Kwiatkowski, Thomas ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

BLEEDING; BLOOD CLOT LYSIS; BRAIN INFARCTION; CANADA; CLINICAL FEATURE; DETERIORATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG EFFICACY; EMERGENCY MEDICINE; HUMAN; LETTER; LONG TERM CARE; PRIORITY JOURNAL; PROGNOSIS; STROKE; TREATMENT OUTCOME;

CANADA; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; FIBRINOLYTIC AGENTS; HUMANS; PROGNOSIS; REGISTRIES; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 34548206750     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.486456     Document Type: Letter

References (3)

1. Dzialowski I, Pexman J, Barber P, Demchuk A, Buchan A, Hill M. Asymptomatic hemorrhage aftr thrombolysis may not be begnign. Stroke. 2007;38:75-79.
2. Libman RB, Kwiatkowski T, Lyden P, Grotta J, Tilley BC, Fagan S, Levine S, Broderick J, Lin Y, Lewandowski C, Frankel M. Asymptomatic hemorrhagic transformation of cerebral infarction does not worsen long-term outcome. Journal of Stroke and Cerebrovascular Diseases. March to April 2, 2005;50-54.
3. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.